Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 4
1986 15
1987 14
1988 30
1989 31
1990 33
1991 76
1992 83
1993 91
1994 98
1995 134
1996 152
1997 138
1998 150
1999 168
2000 144
2001 206
2002 168
2003 199
2004 227
2005 224
2006 239
2007 257
2008 283
2009 272
2010 313
2011 353
2012 406
2013 512
2014 565
2015 595
2016 545
2017 631
2018 1172
2019 1939
2020 2338
2021 2443
2022 2482
2023 2314
2024 629

Text availability

Article attribute

Article type

Publication date

PubMed for id: 766

18,495 results

Results by year

Filters applied: . Clear all
Page 1
ACR Appropriateness Criteria® Staging of Renal Cell Carcinoma: 2022 Update.
Expert Panel on Urological Imaging; Ganeshan D, Khatri G, Ali N, Avery R, Caserta MP, Chang SD, De Leon AD, Gupta RT, Lyshchik A, Michalski J, Nicola R, Pierorazio PM, Purysko AS, Smith AD, Taffel MT, Nikolaidis P. Expert Panel on Urological Imaging, et al. J Am Coll Radiol. 2023 May;20(5S):S246-S264. doi: 10.1016/j.jacr.2023.02.008. J Am Coll Radiol. 2023. PMID: 37236747
ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Carcinoma: 2021 Update.
Expert Panel on Urological Imaging; Purysko AS, Nikolaidis P, Khatri G, Auron M, De Leon AD, Ganeshan D, Gore JL, Gupta RT, Shek-Man Lo S, Lyshchik A, Savage SJ, Smith AD, Taffel MT, Yoo DC, Lockhart ME. Expert Panel on Urological Imaging, et al. J Am Coll Radiol. 2022 May;19(5S):S156-S174. doi: 10.1016/j.jacr.2022.02.015. J Am Coll Radiol. 2022. PMID: 35550799
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update.
Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S, Fernández-Pello S, Giles RH, Hofmann F, Hora M, Klatte T, Kuusk T, Lam TB, Marconi L, Powles T, Tahbaz R, Volpe A, Bex A. Ljungberg B, et al. Eur Urol. 2022 Oct;82(4):399-410. doi: 10.1016/j.eururo.2022.03.006. Epub 2022 Mar 26. Eur Urol. 2022. PMID: 35346519 Free article.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma.
Kanesvaran R, Porta C, Wong A, Powles T, Ng QS, Schmidinger M, Ye D, Malhotra H, Miura Y, Lee JL, Chong FLT, Pu YS, Yen CC, Saad M, Lee HJ, Kitamura H, Bhattacharyya GS, Curigliano G, Poon E, Choo SP, Peters S, Lim E, Yoshino T, Pentheroudakis G. Kanesvaran R, et al. ESMO Open. 2021 Dec;6(6):100304. doi: 10.1016/j.esmoop.2021.100304. Epub 2021 Dec 1. ESMO Open. 2021. PMID: 34864348 Free PMC article.
Systemic treatment of advanced/metastatic renal cell carcinoma in the context of SARS-CoV-2 pandemic: recommendations from the interdisciplinary working group for renal tumors (IAG-N).
Ivanyi P, Grüllich C, Kroeger N, Gauler T, Johannsen M, Bedke J, Grünwald V; Interdisciplinary working group on renal tumors (IAG-N) of the German Cancer Socity (DKG). Ivanyi P, et al. J Cancer Res Clin Oncol. 2020 Nov;146(11):3075-3078. doi: 10.1007/s00432-020-03341-4. Epub 2020 Aug 20. J Cancer Res Clin Oncol. 2020. PMID: 32816108 Free PMC article.
Percutaneous microwave ablation of renal cell carcinoma: practice guidelines of the ultrasound committee of Chinese medical association, interventional oncology committee of Chinese research hospital association.
Yu J, Yu XL, Cheng ZG, Hu B, Han ZY, Liu FY, Hu ZQ, Wang H, Dong J, Pan J, Yang B, Sai X, Guo AT, Liang P. Yu J, et al. Int J Hyperthermia. 2020;37(1):827-835. doi: 10.1080/02656736.2020.1779356. Int J Hyperthermia. 2020. PMID: 32635839 Free article.
Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma.
Albiges L, Powles T, Staehler M, Bensalah K, Giles RH, Hora M, Kuczyk MA, Lam TB, Ljungberg B, Marconi L, Merseburger AS, Volpe A, Abu-Ghanem Y, Dabestani S, Fernández-Pello S, Hofmann F, Kuusk T, Tahbaz R, Bex A. Albiges L, et al. Eur Urol. 2019 Aug;76(2):151-156. doi: 10.1016/j.eururo.2019.05.022. Eur Urol. 2019. PMID: 31151678
18,495 results
You have reached the last available page of results. Please see the User Guide for more information.